Children's of Alabama
12
4
7
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
25%
3 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
Role: collaborator
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
Role: collaborator
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Role: collaborator
Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population
Role: collaborator
Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors
Role: collaborator
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
Role: collaborator
Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD
Role: collaborator
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Role: collaborator
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
Role: collaborator
Pediatric Acute Kidney Injury in COVID-19
Role: collaborator
Telemedicine in Spina Bifida Transition: A Pilot Study
Role: collaborator
Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part IV
Role: collaborator
All 12 trials loaded